These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 974246)

  • 41. [Primary immunodeficiencies and purine metabolism].
    Romo Cortina A; Lorente Toledano F; Salazar Villalobos V
    Rev Clin Esp; 1985 Oct; 177(6):247-53. PubMed ID: 3001848
    [No Abstract]   [Full Text] [Related]  

  • 42. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Morgan G; Levinsky RJ; Hugh-Jones K; Fairbanks LD; Morris GS; Simmonds HA
    Clin Exp Immunol; 1987 Dec; 70(3):491-9. PubMed ID: 3436096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenosine deaminase deficiency and severe combined immunodeficiency disease.
    Thompson LF; Seegmiller JE
    Adv Enzymol Relat Areas Mol Biol; 1980; 51():167-210. PubMed ID: 6255772
    [No Abstract]   [Full Text] [Related]  

  • 44. Failure to thrive and orocutaneous candidiasis in a 3-month-old female.
    Trivedi R; Hopp R; Kobayashi R; Townley R
    Ann Allergy; 1987 Sep; 59(3):175, 224-6. PubMed ID: 3631651
    [No Abstract]   [Full Text] [Related]  

  • 45. Ecto-5'-nucleotidase deficiency: association with adenosine deaminase deficiency and nonassociation with deoxyadenosine toxicity.
    Boss GR; Thompson LF; O'Connor RD; Ziering RW; Seegmiller JE
    Clin Immunol Immunopathol; 1981 Apr; 19(1):1-7. PubMed ID: 6260402
    [No Abstract]   [Full Text] [Related]  

  • 46. Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
    Ammann AJ; Cowan MJ; Martin DW; Wara DW
    Birth Defects Orig Artic Ser; 1983; 19(3):117-20. PubMed ID: 6652234
    [No Abstract]   [Full Text] [Related]  

  • 47. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
    Uberti J; Peterson WD; Lightbody JJ; Johnson RM
    J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic basis for immune dysfunction in adenosine deaminase deficiency.
    Carson DA; Iizasa T; Seto S; Carrera CJ; Kubota M; Willis EH; Wasson DB; Kajander O
    Ann N Y Acad Sci; 1985; 451():34-41. PubMed ID: 3878120
    [No Abstract]   [Full Text] [Related]  

  • 49. MLC vs CML in a case of T-cell immunodeficiency and ADA deficiency.
    Cohen F
    Birth Defects Orig Artic Ser; 1975; 11(1):486-8. PubMed ID: 125120
    [No Abstract]   [Full Text] [Related]  

  • 50. Family study on the kindred of an adenosine deaminase deficient child with severe combined immunodeficiency.
    Lee CH; Ziegler JB; Rozenberg MC
    Aust N Z J Med; 1979 Oct; 9(5):530-3. PubMed ID: 294907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immune deficiencies secondary to enzymopathies].
    Pérignon JL; Hamet M
    Ann Pediatr (Paris); 1989 Jun; 36(6):381-5. PubMed ID: 2502942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radioimmunochemical quantitation of human adenosine deaminase.
    Daddona PE; Frohman MA; Kelley WN
    J Clin Invest; 1979 Sep; 64(3):798-803. PubMed ID: 468994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative immunoassay of adenosine deaminase in combined immunodeficiency disease.
    Carson DA; Goldblum R; Seegmiller JE
    J Immunol; 1977 Jan; 118(1):270-3. PubMed ID: 830750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Adenosine deaminase deficiency in primary immunodeficiencies (author's transl)].
    Belohradsky BH; Hennig N; Marget W; Fudenberg HH
    Klin Wochenschr; 1976 Dec; 54(23):1109-15. PubMed ID: 1003869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential deoxyadenosine toxicity to immature rabbit cartilage in vitro. A model for the chondro-osseous dysplasia of adenosine deaminase deficiency.
    Wortmann RL; Veum JA; Ryan LM; Cheung HS
    Arthritis Rheum; 1989 Aug; 32(8):1014-21. PubMed ID: 2788422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accumulation of deoxyribonucleotides as a possible mediator of immunosuppression in hereditary deficiency of adenosine deaminase.
    Bluestein HG; Willis RC; Thompson LF; Matsumoto S; Seegmiller JE
    Trans Assoc Am Physicians; 1978; 91():394-402. PubMed ID: 314193
    [No Abstract]   [Full Text] [Related]  

  • 57. [Enzyme defects and primary immunodeficiencies (author's transl)].
    Ito K
    Rinsho Byori; 1979 Dec; 27(12):1075-8. PubMed ID: 120452
    [No Abstract]   [Full Text] [Related]  

  • 58. Partial resolution of bone lesions. A child with severe combined immunodeficiency disease and adenosine deaminase deficiency after enzyme-replacement therapy.
    Yulish BS; Stern RC; Polmar SH
    Am J Dis Child; 1980 Jan; 134(1):61-3. PubMed ID: 7350788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human gene therapy. Approval next time round?
    Gershon D
    Nature; 1990 Jun; 345(6275):468. PubMed ID: 2348856
    [No Abstract]   [Full Text] [Related]  

  • 60. Adenosine deaminase and immune dysfunction. Biochemical correlates defined by molecular analysis throughout a disease course.
    Coleman MS; Danton MJ; Philips A
    Ann N Y Acad Sci; 1985; 451():54-65. PubMed ID: 3878121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.